Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 129 entries
Sorted by: Best Match Show Resources per page
Assessment of LV ejection fraction using real-time 3D echocardiography in daily practice: direct comparison of the volumetric and speckle tracking methodologies to CMR.

Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation

Driessen MM, Kort E, Cramer MJ, Doevendans PA, Angevaare MJ, Leiner T, Meijboom FJ, Chamuleau SA, Sieswerda GT.
PMID: 25143268
Neth Heart J. 2014 Sep;22(9):383-90. doi: 10.1007/s12471-014-0577-1.

AIMS: This study is the first to directly compare two widely used real-time 3D echocardiography (RT3DE) methods of cardiac magnetic resonance imaging (CMR) and assess their reproducibility in experienced and less experienced observers.METHODS: Consecutive patients planned for CMR underwent...

Cite
Driessen MM, Kort E, Cramer MJ, et al. Assessment of LV ejection fraction using real-time 3D echocardiography in daily practice: direct comparison of the volumetric and speckle tracking methodologies to CMR. Neth Heart J. 2014;22(9):383-90doi: 10.1007/s12471-014-0577-1.
Driessen, M. M., Kort, E., Cramer, M. J., Doevendans, P. A., Angevaare, M. J., Leiner, T., Meijboom, F. J., Chamuleau, S. A., & Sieswerda, G. T. (2014). Assessment of LV ejection fraction using real-time 3D echocardiography in daily practice: direct comparison of the volumetric and speckle tracking methodologies to CMR. Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation, 22(9), 383-90. https://doi.org/10.1007/s12471-014-0577-1
Driessen, M M P, et al. "Assessment of LV ejection fraction using real-time 3D echocardiography in daily practice: direct comparison of the volumetric and speckle tracking methodologies to CMR." Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation vol. 22,9 (2014): 383-90. doi: https://doi.org/10.1007/s12471-014-0577-1
Driessen MM, Kort E, Cramer MJ, Doevendans PA, Angevaare MJ, Leiner T, Meijboom FJ, Chamuleau SA, Sieswerda GT. Assessment of LV ejection fraction using real-time 3D echocardiography in daily practice: direct comparison of the volumetric and speckle tracking methodologies to CMR. Neth Heart J. 2014 Sep;22(9):383-90. doi: 10.1007/s12471-014-0577-1. PMID: 25143268; PMCID: PMC4160459.
Copy Download .nbib Format: NLM
Stent thrombosis in real-world patients: a comparison of drug-eluting with bare metal stents.

Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation

de Man FH, Stella PR, Nathoe H, Kirkels H, Hamer B, Meijburg HW, Doevendans PA.
PMID: 18176640
Neth Heart J. 2007;15(11):382-6. doi: 10.1007/BF03086019.

BACKGROUND: Although the introduction of drugeluting stents (DES) has been associated with an impressive reduction in target vessel revascularisation, there has been concern about the safety profile. The aim of this study was to determine the incidence of stent...

Cite
de Man FH, Stella PR, Nathoe H, et al. Stent thrombosis in real-world patients: a comparison of drug-eluting with bare metal stents. Neth Heart J. 2007;15(11):382-6doi: 10.1007/BF03086019.
de Man, F. H., Stella, P. R., Nathoe, H., Kirkels, H., Hamer, B., Meijburg, H. W., & Doevendans, P. A. (2007). Stent thrombosis in real-world patients: a comparison of drug-eluting with bare metal stents. Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation, 15(11), 382-6. https://doi.org/10.1007/BF03086019
de Man, F H, et al. "Stent thrombosis in real-world patients: a comparison of drug-eluting with bare metal stents." Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation vol. 15,11 (2007): 382-6. doi: https://doi.org/10.1007/BF03086019
de Man FH, Stella PR, Nathoe H, Kirkels H, Hamer B, Meijburg HW, Doevendans PA. Stent thrombosis in real-world patients: a comparison of drug-eluting with bare metal stents. Neth Heart J. 2007;15(11):382-6. doi: 10.1007/BF03086019. PMID: 18176640; PMCID: PMC2082083.
Copy Download .nbib Format: NLM
Bone marrow cell therapy after acute myocardial infarction: the HEBE trial in perspective, first results.

Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation

van der Laan A, Hirsch A, Nijveldt R, van der Vleuten PA, van der Giessen WJ, Doevendans PA, Waltenberger J, Ten Berg JM, Aengevaeren WR, Zwaginga JJ, Biemond BJ, van Rossum AC, Tijssen JG, Zijlstra F, Piek JJ.
PMID: 19127324
Neth Heart J. 2008 Dec;16(12):436-9. doi: 10.1007/BF03086194.

During the last decennium, the role of bone marrow mononuclear cells (BMMC) has been underscored in the healing process after acute myocardial infarction (AMI). Although these cells improve left ventricular recovery after AMI in experimental studies, results from large-scale...

Cite
van der Laan A, Hirsch A, Nijveldt R, et al. Bone marrow cell therapy after acute myocardial infarction: the HEBE trial in perspective, first results. Neth Heart J. 2008;16(12):436-9doi: 10.1007/BF03086194.
van der Laan, A., Hirsch, A., Nijveldt, R., van der Vleuten, P. A., van der Giessen, W. J., Doevendans, P. A., Waltenberger, J., Ten Berg, J. M., Aengevaeren, W. R., Zwaginga, J. J., Biemond, B. J., van Rossum, A. C., Tijssen, J. G., Zijlstra, F., & Piek, J. J. (2008). Bone marrow cell therapy after acute myocardial infarction: the HEBE trial in perspective, first results. Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation, 16(12), 436-9. https://doi.org/10.1007/BF03086194
van der Laan, A, et al. "Bone marrow cell therapy after acute myocardial infarction: the HEBE trial in perspective, first results." Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation vol. 16,12 (2008): 436-9. doi: https://doi.org/10.1007/BF03086194
van der Laan A, Hirsch A, Nijveldt R, van der Vleuten PA, van der Giessen WJ, Doevendans PA, Waltenberger J, Ten Berg JM, Aengevaeren WR, Zwaginga JJ, Biemond BJ, van Rossum AC, Tijssen JG, Zijlstra F, Piek JJ. Bone marrow cell therapy after acute myocardial infarction: the HEBE trial in perspective, first results. Neth Heart J. 2008 Dec;16(12):436-9. doi: 10.1007/BF03086194. PMID: 19127324; PMCID: PMC2612115.
Copy Download .nbib Format: NLM
Stem cells for cardiac repair: an introduction.

Journal of geriatric cardiology : JGC

du Pré BC, Doevendans PA, van Laake LW.
PMID: 23888179
J Geriatr Cardiol. 2013 Jun;10(2):186-97. doi: 10.3969/j.issn.1671-5411.2013.02.003.

Cardiovascular disease is a major cause of morbidity and mortality throughout the world. Most cardiovascular diseases, such as ischemic heart disease and cardiomyopathy, are associated with loss of functional cardiomyocytes. Unfortunately, the heart has a limited regenerative capacity and...

Cite
du Pré BC, Doevendans PA, van Laake LW. Stem cells for cardiac repair: an introduction. J Geriatr Cardiol. 2013;10(2):186-97doi: 10.3969/j.issn.1671-5411.2013.02.003.
du Pré, B. C., Doevendans, P. A., & van Laake, L. W. (2013). Stem cells for cardiac repair: an introduction. Journal of geriatric cardiology : JGC, 10(2), 186-97. https://doi.org/10.3969/j.issn.1671-5411.2013.02.003
du Pré, Bastiaan C, et al. "Stem cells for cardiac repair: an introduction." Journal of geriatric cardiology : JGC vol. 10,2 (2013): 186-97. doi: https://doi.org/10.3969/j.issn.1671-5411.2013.02.003
du Pré BC, Doevendans PA, van Laake LW. Stem cells for cardiac repair: an introduction. J Geriatr Cardiol. 2013 Jun;10(2):186-97. doi: 10.3969/j.issn.1671-5411.2013.02.003. PMID: 23888179; PMCID: PMC3708059.
Copy Download .nbib Format: NLM
Beta-blocker therapy in unstable severe heart failure, evidence or experience?.

Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation

Meuwese CL, Kirkels JH, de Jonge N, Nathoe HM, Doevendans PA, Klöpping C.
PMID: 23239450
Neth Heart J. 2013 Jan;21(1):3-5. doi: 10.1007/s12471-012-0366-7.

Currently, no evidence exists on the effects of beta-receptor blocker (BRB) treatment in patients with unstable severe heart failure. When confronted with this specific patient category, clinical experience in our centre has consistently guided us to lower the dose...

Cite
Meuwese CL, Kirkels JH, de Jonge N, et al. Beta-blocker therapy in unstable severe heart failure, evidence or experience?. Neth Heart J. 2013;21(1):3-5doi: 10.1007/s12471-012-0366-7.
Meuwese, C. L., Kirkels, J. H., de Jonge, N., Nathoe, H. M., Doevendans, P. A., & Klöpping, C. (2013). Beta-blocker therapy in unstable severe heart failure, evidence or experience?. Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation, 21(1), 3-5. https://doi.org/10.1007/s12471-012-0366-7
Meuwese, C L, et al. "Beta-blocker therapy in unstable severe heart failure, evidence or experience?." Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation vol. 21,1 (2013): 3-5. doi: https://doi.org/10.1007/s12471-012-0366-7
Meuwese CL, Kirkels JH, de Jonge N, Nathoe HM, Doevendans PA, Klöpping C. Beta-blocker therapy in unstable severe heart failure, evidence or experience?. Neth Heart J. 2013 Jan;21(1):3-5. doi: 10.1007/s12471-012-0366-7. PMID: 23239450; PMCID: PMC3528855.
Copy Download .nbib Format: NLM
Peripartum cardiomyopathy: the need for a national database.

Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation

Lok SI, Kirkels JH, Klöpping C, Doevendans PA, de Jonge N.
PMID: 21475400
Neth Heart J. 2011 Mar;19(3):126-133. doi: 10.1007/s12471-011-0083-7. Epub 2011 Jan 27.

Peripartum cardiomyopathy (PPCM) is a rare and life-threatening disease that affects young women in the last month of pregnancy or within 5 months of delivery. It is a form of dilated cardiomyopathy with left-sided systolic dysfunction. The incidence rate...

Cite
Lok SI, Kirkels JH, Klöpping C, et al. Peripartum cardiomyopathy: the need for a national database. Neth Heart J. 2011;19(3):126-133doi: 10.1007/s12471-011-0083-7.
Lok, S. I., Kirkels, J. H., Klöpping, C., Doevendans, P. A., & de Jonge, N. (2011). Peripartum cardiomyopathy: the need for a national database. Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation, 19(3), 126-133. https://doi.org/10.1007/s12471-011-0083-7
Lok, S I, et al. "Peripartum cardiomyopathy: the need for a national database." Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation vol. 19,3 (2011): 126-133. doi: https://doi.org/10.1007/s12471-011-0083-7
Lok SI, Kirkels JH, Klöpping C, Doevendans PA, de Jonge N. Peripartum cardiomyopathy: the need for a national database. Neth Heart J. 2011 Mar;19(3):126-133. doi: 10.1007/s12471-011-0083-7. Epub 2011 Jan 27. PMID: 21475400; PMCID: PMC3047689.
Copy Download .nbib Format: NLM
One-year clinical follow-up of a registry evaluating a percutaneous revascularisation strategy combining a pre-specified simple selection process with the use of a new thin-strut bare cobalt-chromium stent.

Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation

Stella PR, Pavlakis G, Agostoni P, Nathoe HM, Hoseyni Guyomi S, Hamer BJ, Wildbergh TX, Doevendans PA, Van Belle E.
PMID: 20978593
Neth Heart J. 2010 Oct;18(10):486-92. doi: 10.1007/BF03091820.

Objectives. To evaluate clinical events in a specifically selected cohort of patients with obstructive coronary artery disease (CAD), using a new generation thin-strut bare cobalt-chromium coronary stent.Methods. Patients with single- or multi-vessel, stable or unstable CAD eligible for percutaneous...

Cite
Stella PR, Pavlakis G, Agostoni P, et al. One-year clinical follow-up of a registry evaluating a percutaneous revascularisation strategy combining a pre-specified simple selection process with the use of a new thin-strut bare cobalt-chromium stent. Neth Heart J. 2010;18(10):486-92doi: 10.1007/BF03091820.
Stella, P. R., Pavlakis, G., Agostoni, P., Nathoe, H. M., Hoseyni Guyomi, S., Hamer, B. J., Wildbergh, T. X., Doevendans, P. A., & Van Belle, E. (2010). One-year clinical follow-up of a registry evaluating a percutaneous revascularisation strategy combining a pre-specified simple selection process with the use of a new thin-strut bare cobalt-chromium stent. Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation, 18(10), 486-92. https://doi.org/10.1007/BF03091820
Stella, P R, et al. "One-year clinical follow-up of a registry evaluating a percutaneous revascularisation strategy combining a pre-specified simple selection process with the use of a new thin-strut bare cobalt-chromium stent." Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation vol. 18,10 (2010): 486-92. doi: https://doi.org/10.1007/BF03091820
Stella PR, Pavlakis G, Agostoni P, Nathoe HM, Hoseyni Guyomi S, Hamer BJ, Wildbergh TX, Doevendans PA, Van Belle E. One-year clinical follow-up of a registry evaluating a percutaneous revascularisation strategy combining a pre-specified simple selection process with the use of a new thin-strut bare cobalt-chromium stent. Neth Heart J. 2010 Oct;18(10):486-92. doi: 10.1007/BF03091820. PMID: 20978593; PMCID: PMC2954301.
Copy Download .nbib Format: NLM
Journal metrics for the Netherlands Heart Journal.

Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation

van der Wall EE, de Boer MJ, Doevendans PA, Wilde AA, Zijlstra F.
PMID: 21475678
Neth Heart J. 2011 Apr;19(4):159-161. doi: 10.1007/s12471-011-0099-z. Epub 2011 Mar 03.

No abstract available.

Cite
van der Wall EE, de Boer MJ, Doevendans PA, et al. Journal metrics for the Netherlands Heart Journal. Neth Heart J. 2011;19(4):159-161doi: 10.1007/s12471-011-0099-z.
van der Wall, E. E., de Boer, M. J., Doevendans, P. A., Wilde, A. A., & Zijlstra, F. (2011). Journal metrics for the Netherlands Heart Journal. Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation, 19(4), 159-161. https://doi.org/10.1007/s12471-011-0099-z
van der Wall, E E, et al. "Journal metrics for the Netherlands Heart Journal." Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation vol. 19,4 (2011): 159-161. doi: https://doi.org/10.1007/s12471-011-0099-z
van der Wall EE, de Boer MJ, Doevendans PA, Wilde AA, Zijlstra F. Journal metrics for the Netherlands Heart Journal. Neth Heart J. 2011 Apr;19(4):159-161. doi: 10.1007/s12471-011-0099-z. Epub 2011 Mar 03. PMID: 21475678; PMCID: PMC3058508.
Copy Download .nbib Format: NLM
Publisher Correction: Optimization of large animal MI models; a systematic analysis of control groups from preclinical studies.

Scientific reports

Zwetsloot PP, Kouwenberg LHJA, Sena ES, Eding JE, den Ruijter HM, Sluijter JPG, Pasterkamp G, Doevendans PA, Hoefer IE, Chamuleau SAJ, van Hout GPJ, Jansen Of Lorkeers SJ.
PMID: 29643426
Sci Rep. 2018 Apr 11;8(1):6047. doi: 10.1038/s41598-018-23615-9.

A correction to this article has been published and is linked from the HTML and PDF versions of this paper. The error has been fixed in the paper.

Cite
Zwetsloot PP, Kouwenberg LHJA, Sena ES, et al. Publisher Correction: Optimization of large animal MI models; a systematic analysis of control groups from preclinical studies. Sci Rep. 2018;8(1):6047doi: 10.1038/s41598-018-23615-9.
Zwetsloot, P. P., Kouwenberg, L. H. J. A., Sena, E. S., Eding, J. E., den Ruijter, H. M., Sluijter, J. P. G., Pasterkamp, G., Doevendans, P. A., Hoefer, I. E., Chamuleau, S. A. J., van Hout, G. P. J., & Jansen Of Lorkeers, S. J. (2018). Publisher Correction: Optimization of large animal MI models; a systematic analysis of control groups from preclinical studies. Scientific reports, 8(1), 6047. https://doi.org/10.1038/s41598-018-23615-9
Zwetsloot, P P, et al. "Publisher Correction: Optimization of large animal MI models; a systematic analysis of control groups from preclinical studies." Scientific reports vol. 8,1 (2018): 6047. doi: https://doi.org/10.1038/s41598-018-23615-9
Zwetsloot PP, Kouwenberg LHJA, Sena ES, Eding JE, den Ruijter HM, Sluijter JPG, Pasterkamp G, Doevendans PA, Hoefer IE, Chamuleau SAJ, van Hout GPJ, Jansen Of Lorkeers SJ. Publisher Correction: Optimization of large animal MI models; a systematic analysis of control groups from preclinical studies. Sci Rep. 2018 Apr 11;8(1):6047. doi: 10.1038/s41598-018-23615-9. PMID: 29643426; PMCID: PMC5895584.
Copy Download .nbib Format: NLM
Cancer Therapy-Related Cardiac Dysfunction of Nonanthracycline Chemotherapeutics: What Is the Evidence?.

JACC. CardioOncology

Kamphuis JAM, Linschoten M, Cramer MJ, Gort EH, van Rhenen A, Asselbergs FW, Doevendans PA, Teske AJ.
PMID: 34396190
JACC CardioOncol. 2019 Dec 17;1(2):280-290. doi: 10.1016/j.jaccao.2019.09.007. eCollection 2019 Dec.

Cancer therapy-related cardiac dysfunction (CTRCD) is one of the most concerning cardiovascular side effects of cancer treatment. Important reviews within the field of cardio-oncology have described various agents to be associated with a high risk of CTRCD, including mitomycin...

Cite
Kamphuis JAM, Linschoten M, Cramer MJ, et al. Cancer Therapy-Related Cardiac Dysfunction of Nonanthracycline Chemotherapeutics: What Is the Evidence?. JACC CardioOncol. 2019;1(2):280-290doi: 10.1016/j.jaccao.2019.09.007.
Kamphuis, J. A. M., Linschoten, M., Cramer, M. J., Gort, E. H., van Rhenen, A., Asselbergs, F. W., Doevendans, P. A., & Teske, A. J. (2019). Cancer Therapy-Related Cardiac Dysfunction of Nonanthracycline Chemotherapeutics: What Is the Evidence?. JACC. CardioOncology, 1(2), 280-290. https://doi.org/10.1016/j.jaccao.2019.09.007
Kamphuis, Janine A M, et al. "Cancer Therapy-Related Cardiac Dysfunction of Nonanthracycline Chemotherapeutics: What Is the Evidence?." JACC. CardioOncology vol. 1,2 (2019): 280-290. doi: https://doi.org/10.1016/j.jaccao.2019.09.007
Kamphuis JAM, Linschoten M, Cramer MJ, Gort EH, van Rhenen A, Asselbergs FW, Doevendans PA, Teske AJ. Cancer Therapy-Related Cardiac Dysfunction of Nonanthracycline Chemotherapeutics: What Is the Evidence?. JACC CardioOncol. 2019 Dec 17;1(2):280-290. doi: 10.1016/j.jaccao.2019.09.007. eCollection 2019 Dec. PMID: 34396190; PMCID: PMC8352330.
Copy Download .nbib Format: NLM
Cardiovascular Morbidity and Mortality in Adult Patients With Repaired Aortic Coarctation.

Journal of the American Heart Association

Meijs TA, Minderhoud SCS, Muller SA, de Winter RJ, Mulder BJM, van Melle JP, Hoendermis ES, van Dijk APJ, Zuithoff NPA, Krings GJ, Doevendans PA, Witsenburg M, Roos-Hesselink JW, van den Bosch AE, Bouma BJ, Voskuil M.
PMID: 34755532
J Am Heart Assoc. 2021 Nov 16;10(22):e023199. doi: 10.1161/JAHA.121.023199. Epub 2021 Nov 10.

Background The long-term burden of cardiovascular disease after repair of coarctation of the aorta (CoA) has not been elucidated. We aimed to determine the incidence of and risk factors for cardiovascular events in adult patients with repaired CoA. Additionally,...

Cite
Meijs TA, Minderhoud SCS, Muller SA, et al. Cardiovascular Morbidity and Mortality in Adult Patients With Repaired Aortic Coarctation. J Am Heart Assoc. 2021;10(22):e023199doi: 10.1161/JAHA.121.023199.
Meijs, T. A., Minderhoud, S. C. S., Muller, S. A., de Winter, R. J., Mulder, B. J. M., van Melle, J. P., Hoendermis, E. S., van Dijk, A. P. J., Zuithoff, N. P. A., Krings, G. J., Doevendans, P. A., Witsenburg, M., Roos-Hesselink, J. W., van den Bosch, A. E., Bouma, B. J., & Voskuil, M. (2021). Cardiovascular Morbidity and Mortality in Adult Patients With Repaired Aortic Coarctation. Journal of the American Heart Association, 10(22), e023199. https://doi.org/10.1161/JAHA.121.023199
Meijs, Timion A, et al. "Cardiovascular Morbidity and Mortality in Adult Patients With Repaired Aortic Coarctation." Journal of the American Heart Association vol. 10,22 (2021): e023199. doi: https://doi.org/10.1161/JAHA.121.023199
Meijs TA, Minderhoud SCS, Muller SA, de Winter RJ, Mulder BJM, van Melle JP, Hoendermis ES, van Dijk APJ, Zuithoff NPA, Krings GJ, Doevendans PA, Witsenburg M, Roos-Hesselink JW, van den Bosch AE, Bouma BJ, Voskuil M. Cardiovascular Morbidity and Mortality in Adult Patients With Repaired Aortic Coarctation. J Am Heart Assoc. 2021 Nov 16;10(22):e023199. doi: 10.1161/JAHA.121.023199. Epub 2021 Nov 10. PMID: 34755532.
Copy Download .nbib Format: NLM
CT fractional flow reserve: the next level in non-invasive cardiac imaging.

Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation

Meijs MF, Cramer MJ, El Aidi H, Doevendans PA.
PMID: 22826175
Neth Heart J. 2012 Oct;20(10):410-8. doi: 10.1007/s12471-012-0306-6.

The haemodynamic effect of a coronary artery stenosis is a better predictor of prognosis than anatomical lumen obstruction. Until recently, no individual non-invasive test could provide both accurate coronary anatomy and lesion-specific myocardial ischaemia. However, computer tomography (CT) fractional...

Cite
Meijs MF, Cramer MJ, El Aidi H, et al. CT fractional flow reserve: the next level in non-invasive cardiac imaging. Neth Heart J. 2012;20(10):410-8doi: 10.1007/s12471-012-0306-6.
Meijs, M. F., Cramer, M. J., El Aidi, H., & Doevendans, P. A. (2012). CT fractional flow reserve: the next level in non-invasive cardiac imaging. Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation, 20(10), 410-8. https://doi.org/10.1007/s12471-012-0306-6
Meijs, M F L, et al. "CT fractional flow reserve: the next level in non-invasive cardiac imaging." Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation vol. 20,10 (2012): 410-8. doi: https://doi.org/10.1007/s12471-012-0306-6
Meijs MF, Cramer MJ, El Aidi H, Doevendans PA. CT fractional flow reserve: the next level in non-invasive cardiac imaging. Neth Heart J. 2012 Oct;20(10):410-8. doi: 10.1007/s12471-012-0306-6. PMID: 22826175; PMCID: PMC3439547.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 129 entries